
Vera Therapeutics, a developer of treatments for immunological and inflammatory diseases, has secured $80 million in Series C financing. Abingworth LLP led the round.
Source: Press Release
Vera Therapeutics, a developer of treatments for immunological and inflammatory diseases, has secured $80 million in Series C financing.
Vera Therapeutics, a developer of treatments for immunological and inflammatory diseases, has secured $80 million in Series C financing. Abingworth LLP led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination